These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22178465)

  • 21. Comparative evaluation of three semi-quantitative radiographic grading techniques for hip osteoarthritis in terms of validity and reproducibility in 1404 radiographs: report of the OARSI-OMERACT Task Force.
    Gossec L; Jordan JM; Lam MA; Fang F; Renner JB; Davis A; Hawker GA; Dougados M; Maillefert JF;
    Osteoarthritis Cartilage; 2009 Feb; 17(2):182-7. PubMed ID: 18691910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo.
    Bingham CO; Smugar SS; Wang H; Peloso PM; Gammaitoni A
    Pain Med; 2011 Mar; 12(3):352-61. PubMed ID: 21332932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.
    Bingham CO; Buckland-Wright JC; Garnero P; Cohen SB; Dougados M; Adami S; Clauw DJ; Spector TD; Pelletier JP; Raynauld JP; Strand V; Simon LS; Meyer JM; Cline GA; Beary JF
    Arthritis Rheum; 2006 Nov; 54(11):3494-507. PubMed ID: 17075851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis.
    Altman RD; Abadie E; Avouac B; Bouvenot G; Branco J; Bruyere O; Calvo G; Devogelaer JP; Dreiser RL; Herrero-Beaumont G; Kahan A; Kreutz G; Laslop A; Lemmel EM; Menkes CJ; Pavelka K; Van De Putte L; Vanhaelst L; Reginster JY;
    Osteoarthritis Cartilage; 2005 Jan; 13(1):13-9. PubMed ID: 15639632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sample Size Calculations for Detecting Disease-Modifying Osteoarthritis Drug Effects on Knee Replacement Incidence in Clinical Trials: Data From the Osteoarthritis Initiative.
    Ried JS; Flechsenhar K; Bartnik E; Crowther D; Dietrich A; Eckstein F
    Arthritis Rheumatol; 2015 Dec; 67(12):3174-83. PubMed ID: 26314914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee.
    Maksymowych WP; Russell AS; Chiu P; Yan A; Jones N; Clare T; Lambert RG
    Arthritis Res Ther; 2012 Oct; 14(5):R206. PubMed ID: 23036475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial.
    Detert J; Klaus P; Listing J; Höhne-Zimmer V; Braun T; Wassenberg S; Rau R; Buttgereit F; Burmester GR
    Trials; 2014 Oct; 15():412. PubMed ID: 25348033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plain radiography as an outcome measure in clinical trials involving patients with knee osteoarthritis.
    Mazzuca SA; Brandt KD
    Rheum Dis Clin North Am; 1999 May; 25(2):467-80, ix. PubMed ID: 10356429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics.
    Oo WM; Yu SP; Daniel MS; Hunter DJ
    Expert Opin Emerg Drugs; 2018 Dec; 23(4):331-347. PubMed ID: 30415584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI.
    Bellamy N; Bell MJ; Goldsmith CH; Pericak D; Walker V; Raynauld JP; Torrance GW; Tugwell P; Polisson R
    Osteoarthritis Cartilage; 2005 Feb; 13(2):104-10. PubMed ID: 15694571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
    Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
    JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement.
    Gossec L; Paternotte S; Maillefert JF; Combescure C; Conaghan PG; Davis AM; Gunther KP; Hawker G; Hochberg M; Katz JN; Kloppenburg M; Lim K; Lohmander LS; Mahomed NN; March L; Pavelka K; Punzi L; Roos EM; Sanchez-Riera L; Singh JA; Suarez-Almazor ME; Dougados M;
    Osteoarthritis Cartilage; 2011 Feb; 19(2):147-54. PubMed ID: 21044689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiographic joint space width is correlated with 4-year clinical outcomes in patients with knee osteoarthritis: data from the osteoarthritis initiative.
    Oak SR; Ghodadra A; Winalski CS; Miniaci A; Jones MH
    Osteoarthritis Cartilage; 2013 Sep; 21(9):1185-90. PubMed ID: 23973129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon) as a structure modifying therapy in osteoarthritis of the hip and knee.
    Pavelká K; Gatterová J; Gollerova V; Urbanová Z; Sedlácková M; Altman RD
    Osteoarthritis Cartilage; 2000 Sep; 8(5):335-42. PubMed ID: 10966839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to define responders in osteoarthritis.
    Cooper C; Adachi JD; Bardin T; Berenbaum F; Flamion B; Jonsson H; Kanis JA; Pelousse F; Lems WF; Pelletier JP; Martel-Pelletier J; Reiter S; Reginster JY; Rizzoli R; Bruyère O
    Curr Med Res Opin; 2013 Jun; 29(6):719-29. PubMed ID: 23557069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient acceptable symptom state and OMERACT-OARSI set of responder criteria in joint replacement. Identification of cut-off values.
    Escobar A; Gonzalez M; Quintana JM; Vrotsou K; Bilbao A; Herrera-Espiñeira C; Garcia-Perez L; Aizpuru F; Sarasqueta C
    Osteoarthritis Cartilage; 2012 Feb; 20(2):87-92. PubMed ID: 22155074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA.
    Karsdal MA; Bihlet A; Byrjalsen I; Alexandersen P; Ladel C; Michaels M; Andersen JR; Riis BJ; Kraus V; Bay-Jensen AC; Christiansen C
    Osteoarthritis Cartilage; 2015 Apr; 23(4):550-8. PubMed ID: 25576879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial.
    Kahan A; Uebelhart D; De Vathaire F; Delmas PD; Reginster JY
    Arthritis Rheum; 2009 Feb; 60(2):524-33. PubMed ID: 19180484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of avocado-soybean unsaponifiables for the treatment of hip and knee osteoarthritis: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Simental-Mendía M; Sánchez-García A; Acosta-Olivo CA; Vilchez-Cavazos F; Osuna-Garate J; Peña-Martínez VM; Simental-Mendía LE
    Int J Rheum Dis; 2019 Sep; 22(9):1607-1615. PubMed ID: 31328413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.